Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Summary

The purpose of this study is to evaluate the effect of the ABT-869 on the NSCLC subjects.

Timeline

Start

2007-08

Primary completion

2011-06

Completion

2012-06

Publications

• Tan EH, Goss GD, Salgia R, Besse B, Gandara DR, Hanna NH, Yang JC, Thertulien R, Wertheim M, Mazieres J, Hensing T, Lee C, Gupta N, Pradhan R, Qian J, Qin Q, Scappaticci FA, Ricker JL, Carlson DM, Soo RA. Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer. J Thorac Oncol. 2011 Aug;6(8):1418-25. doi: 10.1097/JTO.0b013e318220c93e.

Drugs

Indications